Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Guangdong Bawei Biotechnology OCF Margin %?
Guangdong Bawei BiotechnologyBJSE:920123 42 OCF Margin % is 29.01% as of Jun. 2026, which is 88% above its 10-year median of 15.44. GuruFocus rates BJSE:920123 with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 1,960 Consumer Packaged Goods companies, Guangdong Bawei Biotechnology ranks better than 80.51% on this metric.
The historical rank and industry rank for Guangdong Bawei Biotechnology's OCF Margin % or its related term are showing as below:
BJSE:920123'
s OCF Margin % Range Over the Past 10 Years
Min: 1.03 Med: 15.44 Max: 20.95
Current: 14.99
During the past 13 years, the highest OCF Margin % of Guangdong Bawei Biotechnology was 20.95%. The lowest was 1.03%. And the median was 15.44%.
BJSE:920123's OCF Margin % is ranked better than 80.51% of 1960
companies
in the Consumer Packaged Goods industry
Industry Median: 6.405
vs BJSE:920123: 14.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920123 vs PG, CL, EL: OCF Margin % Comparison
For the Household & Personal Products subindustry, Guangdong Bawei Biotechnology's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Bawei Biotechnology OCF Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Bawei Biotechnology's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Guangdong Bawei Biotechnology's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Bawei Biotechnology (BJSE:920123) has a OCF Margin % of 29.01% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Guangdong Bawei Biotechnology and its competitors. This is 88% above median its historical median of 15.44. Over the past decade, Guangdong Bawei Biotechnology's OCF Margin % has ranged from 1.03 to 20.95. According to the industry distribution chart, Guangdong Bawei Biotechnology ranks #382 out of 1960 companies in the Consumer Packaged Goods industry, placing it in the top 19.5%.
Is Guangdong Bawei Biotechnology's OCF Margin % too high?
Guangdong Bawei Biotechnology's current OCF Margin % of 29.01% is 88% above median its 10-year median of 15.44. Over the past 10 years, this metric has ranged from a low of 1.03 to a high of 20.95. The Consumer Packaged Goods industry median OCF Margin % is 6.41. Guangdong Bawei Biotechnology's value of 29.01% is 352.9% above this industry median. Based on the distribution chart, Guangdong Bawei Biotechnology ranks #382 out of 1960 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Guangdong Bawei Biotechnology has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Bawei Biotechnology's OCF Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Guangdong Bawei Biotechnology ranks #382 out of 1960 companies for OCF Margin %. This places Guangdong Bawei Biotechnology in the top 20% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 6.41. Guangdong Bawei Biotechnology's value of 29.01% is 352.9% above this benchmark. Historically, Guangdong Bawei Biotechnology's own OCF Margin % has ranged from 1.03 to 20.95 over the past decade. While the company's 10-year median is 15.44 vs. the industry median of 6.41, Guangdong Bawei Biotechnology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Consumer Packaged Goods company?
The median OCF Margin % among Consumer Packaged Goods companies is 6.41, based on 1,960 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Bawei Biotechnology's current OCF Margin % of 29.01% is 352.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Guangdong Bawei Biotechnology and its competitors. For the Consumer Packaged Goods industry, the median OCF Margin % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Bawei Biotechnology's current OCF Margin % is 29.01%, which is 88% above median its own 10-year median of 15.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Bawei Biotechnology stock overvalued right now?
Guangdong Bawei Biotechnology (BJSE:920123) has a current OCF Margin % of 29.01%. The current OCF Margin % is 29.01%, which is 88% above median its 10-year median of 15.44 and 352.9% above the Consumer Packaged Goods industry median of 6.41. Guangdong Bawei Biotechnology's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Guangdong Bawei Biotechnology (BJSE:920123), the current OCF Margin % is 29.01% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920123 has been successfully added to your 
